REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 44 filers reported holding REPROS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $6,000 | -33.3% | 4,528 | 0.0% | 0.00% | – |
| Q3 2016 | $9,000 | +28.6% | 4,528 | 0.0% | 0.00% | – |
| Q2 2016 | $7,000 | +75.0% | 4,528 | 0.0% | 0.00% | – |
| Q1 2016 | $4,000 | -20.0% | 4,528 | 0.0% | 0.00% | – |
| Q4 2015 | $5,000 | -85.3% | 4,528 | 0.0% | 0.00% | – |
| Q3 2015 | $34,000 | +6.2% | 4,528 | 0.0% | 0.00% | – |
| Q2 2015 | $32,000 | -77.1% | 4,528 | -72.3% | 0.00% | – |
| Q1 2015 | $140,000 | -0.7% | 16,352 | +15.9% | 0.00% | – |
| Q4 2014 | $141,000 | +0.7% | 14,103 | 0.0% | 0.00% | – |
| Q3 2014 | $140,000 | -45.9% | 14,103 | -5.7% | 0.00% | – |
| Q2 2014 | $259,000 | -13.4% | 14,948 | -11.4% | 0.00% | – |
| Q1 2014 | $299,000 | +4.5% | 16,875 | +7.8% | 0.00% | – |
| Q4 2013 | $286,000 | -25.5% | 15,651 | +9.1% | 0.00% | – |
| Q3 2013 | $384,000 | +82.9% | 14,346 | +26.1% | 0.00% | – |
| Q2 2013 | $210,000 | – | 11,374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 978,800 | $1,292,000 | 0.33% |
| Allegis Investment Advisors, LLC | 344,487 | $455,000 | 0.14% |
| GENERAL AMERICAN INVESTORS CO INC | 589,768 | $778,000 | 0.08% |
| Acrospire Investment Management LLC | 23,177 | $31,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 268,130 | $354,000 | 0.01% |
| Alambic Investment Management, L.P. | 16,091 | $21,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 51,359 | $68,000 | 0.00% |
| Renaissance Technologies | 716,413 | $946,000 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 2,700 | $4,000 | 0.00% |
| Virtu KCG Holdings LLC | 45,144 | $60,000 | 0.00% |